Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think the author might have been an algorithm. These types of articles have 0 value to those that value fundamentals.
Do you mind if I take the content from your posts and put them on the CVM reddit page? You have consistently solid insight...very rare for a public forum.
Biobonic - this is an excellent post. Are you on Reddit?
Thank you for that explanation. I think I will have to read it a few times. :)
Jim - In your chart, you have the Stage III/IVa test arm ultimately doing better than the Stage III test arm. (There seems to be a crossover at about 18 months.) This seems counter-intuitive as a sicker patient population should do worse over time. Am I missing something?
Take a look! https://www.reddit.com/r/cvm/new/
Thanks Jim!
Jim - Sounds good - I will get it posted to the reddit thread. I may even have enough karma (a reddit thing) to put it on some other subreddit boards.
I would be more than happy to walk your son through posting on the reddit thread. He can message me anytime. FrugalNorwegian is my handle.
Jim - I forgot to ask. Would you mind if I post your charts on the CVM reddit page? https://www.reddit.com/r/cvm/ I know a lot of people would appreciate them. Thanks.
Jim - nice job! Are you able to include the '> 6 month survival' inclusion criteria into these charts? I know it isn't easy, but any factor would be helpful.
Robot... May I ask what your handle is on Yahoo?
Do you have any facts to back up your statement?
I created a reddit group if people want to talk about this stock in more depth...and with pictures! https://reddit.com/r/NMTR_Stock/
I can't find that info. Can you provide a link?
I am sure the accounted for misdiagnosis in the 298.
Jim, I am in the process of compiling information about pantheon resources. I would like to do an article on Seeking Alpha in the future. If you have any relevant information, please feel free to forward it to me.
Do you have a SeekingAlpha alias?
Thanks for confirming that, Jim. The only thing I could gather is the fact that the London Stock exchange company is listed in pence, which is 1/100 of a pound. The positive thing to me is that the volume of trades is much higher, than in the states. I don’t get that.
Jim, it looks like there is a similar stock on the London Stock exchange. The ticker is PANR.L. It also appears to have a lot more liquidity. Is this another location to buy Pantheon shares?
I am fairly new at OTC stocks. What is the reason there has been hardly any movement considering they had such a large discovery?
Does this company also trade under the London Stock exchange? There seems to be a similar listing there.
What broker are you using to buy shares?
Do you have a source for these estimates?
Well done, Fosco.
CVM. I would like to hear fung derfs reason on why the stock price dropped on Wednesday.
Please tell me why the stock price is dropping?
Do you know how many shares were sold short this past Wednesday?
The stock is going up dramatically because it is highly under valued at this stage of the P3 trial.
On a sidenote, I also have a son who had brain cancer. Thankfully he beat it.
Will do.
Thanks Fosco. You are a genius. I didn’t pick up on that. We can now “possibly” solve for the success rate.
Should I be using the logarithmic values from the 1st tab or 2nd tab on your spreadsheet?
During Geert’s most recent presentation, he mentioned that the trial should’ve ended two years ago. I first thought this was a sloppy statement. To verify, I duplicated Fosco’s spreadsheet (2nd tab) and learned that Geert’s statement was correct. Assuming a 15% dropout rate and 10% improvement, the trial should’ve ended in November 2017.